Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,055.00    -75.00 (-1.05%)
Bid:
7,050.00
Ask:
7,055.00
Spread: 5.00 (0.071%)
Market Cap: £9.46b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Second Interim Management Statement

6 Aug 2009 07:00

RNS Number : 9498W
Diploma PLC
06 August 2009
 



12 CHARTERHOUSE SQUARE, LONDON EC1M 6AXTELEPHONE: +44 (0)20 7549 5700FACSIMILE: +44 (0)20 7549 5715

FOR IMMEDIATE RELEASE

6 August 2009

DIPLOMA PLC

SECOND INTERIM MANAGEMENT STATEMENT

IN RESPECT OF YEAR ENDING 30 SEPTEMBER 2009

Diploma PLC, the international group of businesses supplying specialised technical products and services, is today issuing its second Interim Management Statement which relates to the period from 1 April 2009 to date.

Trading

The Group has continued to demonstrate its resilient characteristics in the face of the weak trading environment. Revenues for the year to date, in UK sterling, are 1% above the comparable period last year, reflecting similar trends to those reported in the first half of the year. The Group continued to benefit from the contributions from the businesses acquired during the year and from the positive impact, on the translation of the results of overseas businesses, of a weaker UK sterling against the comparable period in 2008. Adjusting for currency effects and acquisitions, revenues for the year to date have decreased by 12%.

In the Life Sciences sector, year to date revenues are 4% ahead of the prior year comparable period, with growth driven principally by the strong performances in the Canadian Healthcare businesses. Revenues from the European businesses continued to be affected by customers delaying capital expenditure, but operating margins are now benefiting from earlier cost reduction initiatives.

The Seals sector businesses continued to face difficult trading conditions, though with some signs of stability now appearing in the core North American businesses. The European seals businesses have been impacted by the downturn in industrial activity in Continental Europe, but trading conditions in the aftermarket sector have stabilised. Operating margins, though still lower than the prior year, are benefiting from cost reductions initiated earlier in the year in the North American businesses and more recently in Europe. Year to date sector revenues in UK sterling terms remain 16% ahead of last year, but have benefited strongly from currency translation and the acquisition of RTD Seals.

In the Controls sector, year to date revenues are 11% down on the prior year comparable period. The UK Controls businesses have continued to experience mixed trading conditions, with Military Aerospace and Defence markets benefiting from ongoing up-grade, refurbishment and maintenance programmes and Calibration services also performing well. However, demand in the Motorsport market has been softer and the general Commercial and Industrial business has been more exposed to the downturn in UK industrial markets. In Germany, the market downturn came later and there has been a greater impact on these businesses from reduced activity in major projects and export led business.

Financial Position

The Group's cash flow generation has continued to be strong, benefiting from the ongoing focus on working capital, with further reductions achieved in stock and debtor balances. As at 31 July 2009, the Group's net cash funds had increased to a level in excess of £12.0m, compared with £5.5m reported at 31 March 2009.

The Group continues to maintain a strong balance sheet, underpinned by a committed multi-currency facility of ca. £18m, which expires in November 2010.

There have been no other material changes in the position of the Group in the period since the publication of the Interim Report for the six months ended 31 March 2009.

Outlook

The Group's recent management results indicate that trading volumes in the Group's key geographic markets are broadly stable and that operating margins are benefiting from cost reduction programmes, commenced earlier in the financial year. The Board therefore remains confident of being able to report results for the year which are in line with current market expectations.

Over the longer term, the Board is satisfied that, with a reduced cost base, the Group is well positioned in its key markets to benefit strongly from a recovery in global economic conditions.

 

Notes:

1. This Interim Management Statement, which is based upon unaudited management accounts, has been prepared solely to provide additional information to the shareholders of Diploma PLC in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Certain statements made in this Statement are forward-looking statements. Such statements have been made by the Directors in good faith using information available up until the date that they approved this Statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

2. The Group's results for the year ending 30 September 2009 are expected to be released in mid November 2009.

 

3. A copy of this Statement, together with further information about Diploma PLC, may be viewed on its website at www.diplomaplc.com

For further enquiries please contact:

Bruce Thompson, Chief Executive Officer

020 7549 5700

Nigel Lingwood, Group Finance Director

020 7549 5705

Simon Bloomfield, Bankside Consultants

020 7367 8861

 

NOTE TO EDITORS:

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

Diploma achieves stable growth and attractive margins from its focus on supplying specialised technical products to markets which value high levels of customer service, technical support and value adding activities. A high proportion of revenues are generated from essential products and services funded by operating, rather than capital budgets.

The Group employs ca. 1,000 employees and its principal operating businesses are located in the UKGermany, US and Canada.

In the last five years ended 30 September 2008, the Group has grown adjusted earnings per share at an average of ca. 21% p.a. through a combination of organic growth and acquisitions. The current market capitalisation is ca. £160m.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDILUGGGCU
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.